We are live on ! Find out more
CMTA

Clementia Pharmaceuticals Inc.
CMTA

Delisted

CMTA was delisted on the 17th of April, 2019.

Back to rankings

38 hedge funds and large institutions have $342M invested in Clementia Pharmaceuticals Inc. in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 6

11% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 9

3% more funds holding

Funds holding: 37 → 38 (+1)

16% less capital invested

Capital invested by funds: $410M → $342M (-$67.3M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
38
Holders Change
+1
Holders Change %
+2.7%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
14
Reduced
6
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$10.5M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$10.2M
3
LCM
Laurion Capital Management
New York
+$3.72M
4
AG
Artal Group
Luxembourg
+$3.25M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$1.46M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$11.1M
2
EC
EcoR1 Capital
California
-$3.69M
3
Citadel Advisors
Citadel Advisors
Florida
-$2.32M
4
EAM
Eventide Asset Management
Massachusetts
-$1.14M
5
Norges Bank
Norges Bank
Norway
-$949K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$158M – – –
Wellington Management Group
2
Wellington Management Group
Massachusetts
$40.6M +$10.2M +629,415 +31%
NMC
3
NEA Management Company
Maryland
$32.4M – – –
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$26.7M +$10.5M +646,459 +58%
DCM
5
Driehaus Capital Management
Illinois
$13.1M +$24.5K +1,504 +0.2%
JP Morgan Chase
6
JP Morgan Chase
New York
$11.3M +$628K +38,572 +5%
Federated Hermes
7
Federated Hermes
Pennsylvania
$10.3M – – –
Fidelity Investments
8
Fidelity Investments
Massachusetts
$7.58M – – –
BlackRock
9
BlackRock
New York
$5.38M -$27K -1,659 -0.5%
RSCM
10
Rock Springs Capital Management
Maryland
$5.23M – – –
PHS
11
PFM Health Sciences
California
$4.89M +$179K +10,977 +4%
BBA
12
Baker Bros. Advisors
New York
$3.79M – – –
LCM
13
Laurion Capital Management
New York
$3.47M +$3.72M +228,754 New
SFM
14
Sphera Funds Management
Israel
$3.03M +$602K +37,000 +23%
AG
15
Artal Group
Luxembourg
$3.03M +$3.25M +200,000 New
WMSA
16
Weiss Multi-Strategy Advisers
New York
$2.73M -$163K -10,000 -5%
Alyeska Investment Group
17
Alyeska Investment Group
Illinois
$2.57M +$1.46M +89,670 +112%
SAM
18
Sectoral Asset Management
Quebec, Canada
$1.7M +$600K +36,900 +49%
DCM
19
DAFNA Capital Management
California
$1.59M +$732K +45,000 +75%
USAA
20
United Services Automobile Association
Texas
$1.29M +$245K +15,055 +21%
UOC
21
UBS O'Connor
Illinois
$665K +$714K +43,866 New
AA
22
ALPS Advisors
Colorado
$620K +$116K +7,116 +21%
BC
23
Birchview Capital
Vermont
$576K +$260K +16,000 +73%
MWNA
24
Marshall Wace North America
New York
$411K +$441K +27,113 New
Morgan Stanley
25
Morgan Stanley
New York
$289K -$41.2K -2,531 -12%
1
2

CMTA Hedge Fund Activity: Q1 2018 in Review

38 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Clementia Pharmaceuticals Inc. (CMTA) for Q1 2018, worth a combined $342M — down 16% from $410M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new CMTA positions and 9 closed out — a net gain of 1 holder — while 14 added to existing stakes and 6 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $10.5M. The largest seller was RA Capital Management, exiting entirely with an estimated $11.1M sold.

  • 38 institutional investors held Clementia Pharmaceuticals Inc. (CMTA) as of Q1 2018, up from 37 in Q4 2017.
  • Funds reported $342M of Clementia Pharmaceuticals Inc. stock for Q1 2018, down 16% quarter-over-quarter.
  • 10 funds opened new Clementia Pharmaceuticals Inc. positions in Q1 2018 and 9 closed out, a net change of +1 holder.
  • The largest Clementia Pharmaceuticals Inc. buyer in Q1 2018 was Janus Henderson Group, an estimated $10.5M added.
  • The largest Clementia Pharmaceuticals Inc. seller in Q1 2018 was RA Capital Management, an estimated $11.1M sold.

Based on aggregated 13F filings for Q1 2018.